Free Trial

Jane Street Group LLC Sells 5,350 Shares of Teleflex Incorporated (NYSE:TFX)

Teleflex logo with Medical background

Jane Street Group LLC trimmed its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 25.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 15,473 shares of the medical technology company's stock after selling 5,350 shares during the period. Jane Street Group LLC's holdings in Teleflex were worth $3,827,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Cromwell Holdings LLC grew its holdings in Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock worth $33,000 after acquiring an additional 49 shares during the last quarter. Avior Wealth Management LLC lifted its holdings in shares of Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after purchasing an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new stake in shares of Teleflex in the third quarter worth $40,000. True Wealth Design LLC increased its holdings in Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock valued at $41,000 after purchasing an additional 166 shares during the period. Finally, GAMMA Investing LLC raised its position in Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company's stock worth $42,000 after purchasing an additional 97 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Wall Street Analyst Weigh In

TFX has been the topic of a number of analyst reports. StockNews.com upgraded Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a report on Friday, November 1st. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Monday. Royal Bank of Canada dropped their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Finally, Truist Financial decreased their price objective on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a research report on Wednesday. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $255.14.

Read Our Latest Stock Analysis on TFX

Teleflex Trading Up 1.2 %

Shares of NYSE:TFX traded up $2.13 during mid-day trading on Thursday, hitting $174.79. The company had a trading volume of 752,001 shares, compared to its average volume of 385,943. The company has a market capitalization of $8.12 billion, a PE ratio of 34.75, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Teleflex Incorporated has a one year low of $171.69 and a one year high of $256.85. The firm has a fifty day moving average price of $203.60 and a 200 day moving average price of $219.66. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business's quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.64 earnings per share. As a group, research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were issued a $0.34 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.78%. Teleflex's payout ratio is currently 27.04%.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Should you invest $1,000 in Teleflex right now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop

The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop

Join tech expert Jeff Brown, the founder of Brownstone Research, as he breaks down what’s driving Tesla's latest rally and how AI is fueling future growth.

Related Videos

Why Meta Is Still a Top Stock Pick for 2025
Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner
Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines